Cited 6 times in
Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.